<- Go Home
Receptech Corporation
Receptech Corporation was formerly a subsidiary of Immunex Corporation. As a result of Immunex Corporation's acquisition by Amgen Inc. as of July 15, 2002, Receptech Corporation was merged into Amgen Inc. Receptech Corporation offers clinical development and drug research services to treat diseases affecting the body's immune system. The company was incorporated in 1989 and is based in Seattle, Washington.
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium